There was a sharp drop in the number of unnecessary prostate cancer hormonal treatments after Medical policy changes reduced reimbursements. However, hormonal therapy for prostate cancer patients who clearly benefited from such therapy continued unaffected, researchers wrote in an article published in the NEJM (New England Journal of Medicine). The authors believe their findings suggest that the health care reforms can reduce waste without affecting effective treatment rates. Lead author, Vahakn B. Shahinian, M.D., M.S... 
More...
More...